A window-of-opportunity clinical trial of dasatinib in women with newly diagnosed endometrial cancer

被引：0
|
作者：
Linda R. Duska
Gina R. Petroni
Heather Lothamer
William Faust
Jan H. Beumer
Susan M. Christner
Anne M. Mills
Paula M. Fracasso
Sarah J. Parsons
机构：
[1] University of Virginia School of Medicine,Department of Obstetrics and Gynecology, Division of Gynecology Oncology
[2] University of Virginia School of Medicine,Department of Microbiology, Immunology, and Cancer Biology
[3] University of Virginia School of Medicine,Department of Public Health Services
[4] UPMC Hillman Cancer Center,Cancer Therapeutics Program
[5] University of Pittsburgh School of Medicine,Division of Hematology
[6] University of Pittsburgh,Oncology, Department of Medicine
[7] University of Virginia School of Medicine,Department of Pharmaceutical Sciences, School of Pharmacy
[8] University of Virginia School of Medicine,Department of Pathology
[9] University of Virginia Cancer Center,Department of Medicine
来源：
Cancer Chemotherapy and Pharmacology | 2019年 / 83卷
关键词：
Dasatinib; Endometrial cancer; Src inhibition; Pharmacodynamics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：473 / 482
页数：9
相关论文
共 50 条
  • [41] Pre-surgical statin-treatment in a window-of-opportunity breast cancer trial: Changes in gene expression profiles
    Bjarnadottir, Olof
    Johansson, Ida
    Veerla, Srinivas
    Jirstrom, Karin
    Grabau, Dorthe
    Hedenfalk, Ingrid
    Borgquist, Signe
    CANCER RESEARCH, 2014, 74 (19)
  • [42] Systemic statin treatment and intra-tumoral lipid metabolism - report from a window-of-opportunity breast cancer trial
    Feldt, Maria
    Menard, Julien
    Belting, Mattias
    Borgquist, Signe
    CANCER RESEARCH, 2015, 75
  • [43] Window-of-opportunity clinical trials for biomarker discovery in head and neck squamous cell carcinoma
    Marret, Gregoire
    Borcoman, Edith
    Le Tourneau, Christophe
    CURRENT OPINION IN ONCOLOGY, 2023, 35 (03) : 158 - 165
  • [44] The Role of Platins in Newly Diagnosed Endometrial Cancer
    Hoskins, Paul J.
    PLATINUM AND OTHER HEAVY METAL COMPOUNDS IN CANCER CHEMOTHERAPY: MOLECULAR MECHANISMS AND CLINICAL APPLICATIONS, 2009, : 307 - 315
  • [45] WINDOW OF OPPORTUNITY: RATE OF REFERRAL TO INFERTILITY PROVIDERS AMONG REPRODUCTIVE AGE WOMEN WITH NEWLY DIAGNOSED GYNECOLOGIC CANCERS
    Frisch, Emily H.
    Chau, Danielle
    Neumann, Olivia
    Kim, Hanna
    Richards, Elliott G.
    Beffa, Lindsey
    FERTILITY AND STERILITY, 2023, 120 (04) : E153 - E153
  • [46] Elacestrant in Women with Estrogen Receptor-Positive and HER2-Negative Early Breast Cancer: Results from the Preoperative Window-of-Opportunity ELIPSE Trial
    Vidal, Maria
    Falato, Claudette
    Pascual, Tomas
    Sanchez-Bayona, Rodrigo
    Munoz-Mateu, Montserrat
    Cebrecos, Isaac
    Gonzalez-Farre, Xavier
    Cortadellas, Tomas
    Vila, Mireia Margeli
    Luna, Miguel A.
    Siso, Christian
    Amillano, Kepa
    Galvan, Patricia
    Bergamino, Milana A.
    Ferrero-Cafiero, Juan M.
    Salvador, Fernando
    Espinosa Guerrero, Alejandra
    Pare, Laia
    Sanfeliu, Esther
    Prat, Aleix
    Bellet, Meritxell
    CLINICAL CANCER RESEARCH, 2025, 31 (07) : 1223 - 1232
  • [47] Biomarker and Tumor Responses of Oral Cavity Squamous Cell Carcinoma to Trametinib: A Phase II Neoadjuvant Window-of-Opportunity Clinical Trial
    Uppaluri, Ravindra
    Winkler, Ashley E.
    Lin, Tianxiang
    Law, Jonathan H.
    Haughey, Bruce H.
    Nussenbaum, Brian
    Paniello, Randal C.
    Rich, Jason T.
    Diaz, Jason A.
    Michel, Loren P.
    Wildes, Tanya
    Dunn, Gavin P.
    Zolkind, Paul
    Kallogjeri, Dorina
    Piccirillo, Jay F.
    Dehdashti, Farrokh
    Siegel, Barry A.
    Chernock, Rebecca D.
    Lewis, James S., Jr.
    Adkins, Douglas R.
    CLINICAL CANCER RESEARCH, 2017, 23 (09) : 2186 - 2194
  • [48] A window-of-opportunity trial using neoadjuvant hepatic artery chemotherapy for patients with localized pancreas cancer: Interim analysis of safety and feasibility
    Agritelley, Ethan S.
    Kanu, Elishama N.
    Bao, Jiayin
    Fletcher, Ashley A.
    Skinner, Holly
    Molvin, Adi
    Murray, Stacy
    Kim, Charles Y.
    Cline, Brendan
    Mastria, Eric
    Johnson, David Y.
    DeVito, Nicholas C.
    Blobe, Gerard C.
    Abbruzzese, James L.
    Crosby, Erika J.
    Martin, Allison
    Mettu, Niharika B.
    Allen, Peter J.
    Nussbaum, Daniel P.
    CANCER RESEARCH, 2024, 84 (17)
  • [49] Exploratory window-of-opportunity trial to investigate the tumor pharmacokinetics/pharmacodynamics of the IAP antagonist Debio 1143 in patients with head and neck cancer
    Gomez-Roca, Carlos
    Even, Caroline
    Le Tourneau, Christophe
    Baste, Neus
    Delord, Jean-Pierre
    Sarini, Jerome
    Vergez, Sebastien
    Temam, Stephane
    Hoffmann, Caroline
    Rochaix, Philippe
    Borcoman, Edith
    Gavillet, Bruno
    Rouits, Elisabeth
    Menetrey, Annick
    Brichory, Franck
    Purcea, Daniela
    Vuagniaux, Gregoire
    Zanna, Claudio
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2022, 15 (01): : 55 - 62
  • [50] Neoadjuvant tamoxifen therapy reactivates tumor suppressor protein p53 in luminal breast cancer patients: Results from a window-of-opportunity clinical trial
    Das, Gokul M.
    Kulkarni, Swati A.
    Oturkar, Chetan
    Rosario, Spencer
    Edge, Stephen B.
    Wang, Jianmin
    Swetzig, Wendy M.
    Hutson, Alan D.
    Kaipparettu, Benny
    Groman, Adrienne
    Adjei, Araba
    Goey, Andrew K.
    Morrison, Carl D.
    Kumar, Shicha
    CANCER RESEARCH, 2023, 83 (05)
12345